News in Brief
Health - Jan 11
Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer
Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer
Pharmacology - Jan 11
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
History - Jan 10
THURS 28 JAN.: MAKING ART MODERN? VIEWS FROM THE ITALIAN RENAISSANCE- Talk by Robert Brennan with a response by Wolf-Dietrich Löhr
THURS 28 JAN.: MAKING ART MODERN? VIEWS FROM THE ITALIAN RENAISSANCE- Talk by Robert Brennan with a response by Wolf-Dietrich Löhr
Environment - Jan 7
More Root Carbon in Extensive Cultivation Systems - the Greenhouse Gas Inventory Is Optimised
More Root Carbon in Extensive Cultivation Systems - the Greenhouse Gas Inventory Is Optimised
Economics - Jan 7
Keep it simple: Exploring the precarious world of economic forecasting with Prof Michael Gasiorek
Keep it simple: Exploring the precarious world of economic forecasting with Prof Michael Gasiorek
science wire
« BACK
Health - Pharmacology - 02.12.2020
Health - Pharmacology - 30.11.2020
Health - Pharmacology - 30.11.2020 
Taco mattresses take the pressure off hospitals
During the lockdown last spring, Julian Ferchow put his doctoral project aside to help relieve the strain on hospitals.
Health - Pharmacology - 25.11.2020
Health - Pharmacology - 25.11.2020
Health - Pharmacology - 25.11.2020 
Infusion more effective than tablets: Treatment of iron anaemia in rural Africa
Iron-deficiency anaemia is a major concern in low income countries, especially for women. A study conducted in Tanzania has now demonstrated the advantage of iron infusion therapy over the usual treatment with iron tablets.
Health - Pharmacology - 25.11.2020
Health - Pharmacology - 24.11.2020
Health - Pharmacology - 24.11.2020
Pharmacology - Health - 24.11.2020
Health - Pharmacology - 24.11.2020
Health - Pharmacology - 23.11.2020
Health - Pharmacology - 20.11.2020
Pharmacology - Health - 20.11.2020
Pharmacology - Health - 20.11.2020
Pharmacology - Health - 19.11.2020
Health - Pharmacology - 19.11.2020
Pharmacology - Health - 19.11.2020
Health - Pharmacology - 18.11.2020
Pharmacology - Health - 18.11.2020
Health - Pharmacology - 18.11.2020
Health - Pharmacology - 17.11.2020
Health - Pharmacology - 17.11.2020
Pharmacology - Health - 13.11.2020
Pharmacology - Environment - 13.11.2020
Pharmacology - Health - 13.11.2020
Pharmacology - Health - 13.11.2020
Pharmacology - Health - 13.11.2020
Health - Pharmacology - 12.11.2020
Pharmacology - Health - 12.11.2020
Health - Pharmacology - 12.11.2020
Health - Pharmacology - 11.11.2020
Health - Pharmacology - 11.11.2020
Health - Pharmacology - 10.11.2020 
Oxford ramps up COVID-19 testing capability
The University of Oxford has joined forces with Thermo Fisher Scientific, the world leader in serving science, to ramp up the university's capacity to deliver COVID-19 testing data. The new rapid testing laboratory and jointly developed Thermo Scientific OmnipathTM Combi SARS-CoV-2 IgG ELISA test detects and quantifies antibodies against the coronavirus and increases the University of Oxford's testing capacity to up to 50,000 tests per day.
Health - Pharmacology - 09.11.2020
Health - Pharmacology - 06.11.2020
Pharmacology - Event - 05.11.2020
Pharmacology - Health - 05.11.2020
Health - Pharmacology - 04.11.2020
Health - Pharmacology - 04.11.2020 
United against COVID
Bavarian alliance "FOR-COVID" researches on possible therapies and vaccinations Contain and treat the coronavirus SARS-CoV-2 as quickly as possible - the Bavarian research alliance "FOR-COVID" will contribute to this with scientific findings relating to the virus and the COVID-19 disease.
Health - Pharmacology - 04.11.2020
Health - Pharmacology - 03.11.2020
Health - Pharmacology - 03.11.2020 
Lack of understanding of common heart condition leads to missed treatment opportunities
Poor awareness of a condition known as Heart Failure with preserved Ejection Fraction (HFpEF) - the cause of a half of all cases of heart failure in England - could be hindering opportunities to improve care for patients, say researchers from the Universities of Cambridge, Manchester, and Keele. We heard some clinicians asking: what's the point of diagnosis if there is no specific treatment? Christi Deaton HFpEF - pronounced 'heff peff' - is a condition whereby heart muscles are too stiff, preventing the organ's chambers from filling properly with blood.
Health - Pharmacology - 02.11.2020
Pharmacology - Health - 02.11.2020
Health - Pharmacology - 30.10.2020 
Contact tracing with prophylactic treatment could near-eliminate leprosy
Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programmes, and is generally well accepted by patients, their contacts, and healthcare workers.
Pharmacology - Health - 30.10.2020
Pharmacology - Health - 30.10.2020
Pharmacology - Health - 29.10.2020
Pharmacology - Health - 29.10.2020
Pharmacology
Results 51 - 100 of 2145.
COVID-19: Fall in cancer treatment rose following ’rapid’ NHS guidance
The number of patients starting anticancer therapies dropped by more than 30 per cent in April, the month following the UK's first COVID-19 lockdown, but went above pre-pandemic levels within three months, finds a new study of NHS England data co-led by UCL researchers.
The number of patients starting anticancer therapies dropped by more than 30 per cent in April, the month following the UK's first COVID-19 lockdown, but went above pre-pandemic levels within three months, finds a new study of NHS England data co-led by UCL researchers.
During the lockdown last spring, Julian Ferchow put his doctoral project aside to help relieve the strain on hospitals.
Opinion: Should Covid-19 vaccines be mandatory?
To be properly protective, Covid-19 vaccines need to be given to most people worldwide. Here, Dr Vageesh Jain (UCL Institute for Global Health) argues against the need for mandatory vaccines, while Dr Alberto Giubilini argues the reverse.
To be properly protective, Covid-19 vaccines need to be given to most people worldwide. Here, Dr Vageesh Jain (UCL Institute for Global Health) argues against the need for mandatory vaccines, while Dr Alberto Giubilini argues the reverse.
Re-starting global economy depends on tackling ’last mile’ of vaccine journey
Re-starting the global economy for billions of people will depend on successfully overcoming logistical challenges in the ‘last mile' of a COVID-19 vaccine's journey to immunisation stations, according to a new report.
Re-starting the global economy for billions of people will depend on successfully overcoming logistical challenges in the ‘last mile' of a COVID-19 vaccine's journey to immunisation stations, according to a new report.
Iron-deficiency anaemia is a major concern in low income countries, especially for women. A study conducted in Tanzania has now demonstrated the advantage of iron infusion therapy over the usual treatment with iron tablets.
Tackling pandemic threats proactively
If we are to minimize the impact of future disease outbreaks, we must recognize the importance of immunization and invest in preemptive vaccine development, writes Tim Keys.
If we are to minimize the impact of future disease outbreaks, we must recognize the importance of immunization and invest in preemptive vaccine development, writes Tim Keys.
"high level" of COVID vaccine resistance
Almost three-in-five Australians (58.5 per cent) say they will definitely get a COVID vaccine once it is available, new analysis from The Australian National University (ANU) shows.
Almost three-in-five Australians (58.5 per cent) say they will definitely get a COVID vaccine once it is available, new analysis from The Australian National University (ANU) shows.
Bristol secures £45M to advance gene therapy treatment of chronic kidney diseases
The University of Bristol has secured a £45million deal to advance its groundbreaking gene therapy technology for chronic kidney diseases.
The University of Bristol has secured a £45million deal to advance its groundbreaking gene therapy technology for chronic kidney diseases.
New clinical trial launched for early treatment of COVID-19
A potential treatment for COVID-19, which has shown early promise in China and Japan, will be trialled in NHSGGC in colloboration with the University of Glasgow.
A potential treatment for COVID-19, which has shown early promise in China and Japan, will be trialled in NHSGGC in colloboration with the University of Glasgow.
Coronavirus: simplified, faster generation of SwissCovid app codes
The process of generating covidcodes has been significantly simplified and accelerated. Persons who have tested positive can enter their code into the SwissCovid app to inform other app users of possible exposure to the virus.
The process of generating covidcodes has been significantly simplified and accelerated. Persons who have tested positive can enter their code into the SwissCovid app to inform other app users of possible exposure to the virus.
More than half of in-hospital deaths from COVID-19 among Black, Hispanic patients
Researchers found that Black and Hispanic people made up 58% of all patients hospitalized for COVID-19 and 53% of those who died from the disease.
Researchers found that Black and Hispanic people made up 58% of all patients hospitalized for COVID-19 and 53% of those who died from the disease.
How to sign up for COVID-19 vaccine trials at UChicago Medicine
The University of Chicago Medicine has launched a registry for individuals to participate in phase 3 trials for a vaccine to fight the virus that causes COVID-19.
The University of Chicago Medicine has launched a registry for individuals to participate in phase 3 trials for a vaccine to fight the virus that causes COVID-19.
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
Pooled data analyses from Phase III ORION-9, -10 and -11 showed that inclisiran consistently reduced low-density lipoprotein cholesterol (LDL-C) by approximately 51% in both male and female adult p
Pooled data analyses from Phase III ORION-9, -10 and -11 showed that inclisiran consistently reduced low-density lipoprotein cholesterol (LDL-C) by approximately 51% in both male and female adult p
Results from real-world data and post-hoc analysis of Novartis Beovu pivotal trials presented at AAO 2020
Initial findings on patient characteristics and event likelihood provide insights related to Beovu use in wet AMD 1,2 Follows establishment of multi-disciplinary expert coalition and Novartis commi
Initial findings on patient characteristics and event likelihood provide insights related to Beovu use in wet AMD 1,2 Follows establishment of multi-disciplinary expert coalition and Novartis commi
The Unequal Spread of COVID-19
The COVID-19 pandemic has flooded communities that are already at a disadvantage, disproportionately affecting underserved populations.
The COVID-19 pandemic has flooded communities that are already at a disadvantage, disproportionately affecting underserved populations.
UofG scientist set to play leading role in ’first of its kind’ clinical trail to bring hope to people with lung cancer
A University of Glasgow scientist is set to play a leading role in a ground breaking clinical trial for people with lung cancer.
A University of Glasgow scientist is set to play a leading role in a ground breaking clinical trial for people with lung cancer.
A few kilograms weight loss nearly halves the risk of diabetes, large scale research study finds
Providing support to help people with prediabetes make small changes to their lifestyle, diet and physical activity can almost halve the risk of developing Type 2 diabetes, according the results of the Norfolk Diabetes Prevention Study (NDPS) the largest diabetes prevention research study in the world in the last 30 years.
Providing support to help people with prediabetes make small changes to their lifestyle, diet and physical activity can almost halve the risk of developing Type 2 diabetes, according the results of the Norfolk Diabetes Prevention Study (NDPS) the largest diabetes prevention research study in the world in the last 30 years.
The University of Oxford has joined forces with Thermo Fisher Scientific, the world leader in serving science, to ramp up the university's capacity to deliver COVID-19 testing data. The new rapid testing laboratory and jointly developed Thermo Scientific OmnipathTM Combi SARS-CoV-2 IgG ELISA test detects and quantifies antibodies against the coronavirus and increases the University of Oxford's testing capacity to up to 50,000 tests per day.
Study aims to REACH out to heart failure patients
The Universities of Dundee, Glasgow, Exeter, Birmingham, Cambridge, and York have received £2.4 million to lead a clinical trial of a home-based cardiac rehabilitation programme for people with heart failure and their caregivers.
The Universities of Dundee, Glasgow, Exeter, Birmingham, Cambridge, and York have received £2.4 million to lead a clinical trial of a home-based cardiac rehabilitation programme for people with heart failure and their caregivers.
Novartis provides update on CAN-COVID trial in hospitalized patients
The Phase III trial investigating canakinumab plus standard of care (SoC) did not meet its primary endpoint of a greater chance of patient survival without the need for invasive mechanical ventilatio
The Phase III trial investigating canakinumab plus standard of care (SoC) did not meet its primary endpoint of a greater chance of patient survival without the need for invasive mechanical ventilatio
Novartis Cosentyx shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study
Significant reduction of synovitis (joint lining inflammation) was demonstrated with Cosentyx at Week 12 vs.
Significant reduction of synovitis (joint lining inflammation) was demonstrated with Cosentyx at Week 12 vs.
Bladder Cancer Research Centre launches at the University of Birmingham
Bladder cancer is relatively common cancer in the UK, with over 10,000 patients diagnosed each year in the UK and approximately 40-50,000 patients living with the disease at any one time.
Bladder cancer is relatively common cancer in the UK, with over 10,000 patients diagnosed each year in the UK and approximately 40-50,000 patients living with the disease at any one time.
Bavarian alliance "FOR-COVID" researches on possible therapies and vaccinations Contain and treat the coronavirus SARS-CoV-2 as quickly as possible - the Bavarian research alliance "FOR-COVID" will contribute to this with scientific findings relating to the virus and the COVID-19 disease.
Dentists admit feeling pressured to offer unnecessary treatments
Most private dentists in Australia earn their wage linked to how much treatment they provide, so this fee-for-service model provides an incentive for them to provide more treatment, rather than less, writes Dr Alexander Holden.
Most private dentists in Australia earn their wage linked to how much treatment they provide, so this fee-for-service model provides an incentive for them to provide more treatment, rather than less, writes Dr Alexander Holden.
Poor awareness of a condition known as Heart Failure with preserved Ejection Fraction (HFpEF) - the cause of a half of all cases of heart failure in England - could be hindering opportunities to improve care for patients, say researchers from the Universities of Cambridge, Manchester, and Keele. We heard some clinicians asking: what's the point of diagnosis if there is no specific treatment? Christi Deaton HFpEF - pronounced 'heff peff' - is a condition whereby heart muscles are too stiff, preventing the organ's chambers from filling properly with blood.
Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programmes, and is generally well accepted by patients, their contacts, and healthcare workers.
Novartis presents latest Phase III data reinforcing Cosentyx as a first-line systemic treatment in pediatric psoriasis
Latest data show Cosentyx provides fast and strong skin clearance, significant improvement in quality of life and a favorable safety profile 1,2 Moderate-to-severe psoriasis affects more than 350,0
Latest data show Cosentyx provides fast and strong skin clearance, significant improvement in quality of life and a favorable safety profile 1,2 Moderate-to-severe psoriasis affects more than 350,0
News in Brief
Health - Jan 11
Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer
Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer
Pharmacology - Jan 11
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
History - Jan 10
THURS 28 JAN.: MAKING ART MODERN? VIEWS FROM THE ITALIAN RENAISSANCE- Talk by Robert Brennan with a response by Wolf-Dietrich Löhr
THURS 28 JAN.: MAKING ART MODERN? VIEWS FROM THE ITALIAN RENAISSANCE- Talk by Robert Brennan with a response by Wolf-Dietrich Löhr
Environment - Jan 7
More Root Carbon in Extensive Cultivation Systems - the Greenhouse Gas Inventory Is Optimised
More Root Carbon in Extensive Cultivation Systems - the Greenhouse Gas Inventory Is Optimised
Economics - Jan 7
Keep it simple: Exploring the precarious world of economic forecasting with Prof Michael Gasiorek
Keep it simple: Exploring the precarious world of economic forecasting with Prof Michael Gasiorek